相似文献/References:
[1]许世琴,张倩,高同举.荧光定量聚合酶链反应检测乙肝病毒DNA的临床意义[J].新乡医学院学报,2001,18(04):292.
[2]焦栓林,许丽芝,申德林,等.拉米夫定治疗慢性乙型肝炎过程中的YMDD变异及其临床意义[J].新乡医学院学报,2002,19(06):465.
[3]焦栓林,许丽芝,申德林,等.拉米夫定治疗慢性乙型肝炎过程中的YMDD变异及其临床意义[J].新乡医学院学报,2002,19(06):465.
[4]许德军,李太平,郎振为.巨细胞病毒在慢性乙型肝炎患者肝组织中的表达[J].新乡医学院学报,2006,23(05):529.
[5]陈占军,丁小华,裴 容,等.综合护理干预对老年乙型肝炎肝硬化合并２型糖尿病患者的影响[J].新乡医学院学报,2014,31(05):405.[doi:10.7683/xxyxyxb.2014.05.026]
[6]叶 明.2种方案阻断乙型肝炎病毒母婴传播效果比较[J].新乡医学院学报,2014,31(11):915.[doi:10.7683/xxyxyxb.2014.11.014]
[7]赵佳,尚文会,田召兵,等.不同商品化试剂盒定量检测肝癌晚期患者乙型肝炎病毒 DNA结果的差异[J].新乡医学院学报,2022,39(12):1155.[doi:10.7683/xxyxyxb.2022.12.010]
ZHAO Jia,SHANG Wenhui,TIAN Zhaobing,et al.Difference of quantitative detection of hepatitis B virus DNA in patients with advanced liver cancer by different commercial kits[J].Journal of Xinxiang Medical University,2022,39(04):1155.[doi:10.7683/xxyxyxb.2022.12.010]
[8]王天宝,王 扬,罗 磊,等.乙型肝炎病毒与戊型肝炎病毒重叠感染患者T淋巴细胞变化及相关临床危险因素分析[J].新乡医学院学报,2018,35(11):1013.[doi:10.7683/xxyxyxb.2018.11.017]
WANG Tian-bao,WANG Yang,LUO Lei,et al.Analysis of T lymphocyte changes and related clinical risk factors in patients with hepatitis B virus and hepatitis E virus superinfection[J].Journal of Xinxiang Medical University,2018,35(04):1013.[doi:10.7683/xxyxyxb.2018.11.017]
[9]王树俊,孙会潇,徐 侠,等.去甲斑蝥素片联合替诺福韦酯治疗失代偿期肝硬化疗效观察[J].新乡医学院学报,2021,38(5):458.[doi:10.7683/xxyxyxb.2021.05.013]
WANG Shujun,SUN Huixiao,XU Xia,et al.Effect of norcantharidin tablets combined with tenofovir disoprox in the treatment of decompensated cirrhosis[J].Journal of Xinxiang Medical University,2021,38(04):458.[doi:10.7683/xxyxyxb.2021.05.013]
[10]杨 鑫,杨道坤.Toll样受体在慢性乙型肝炎患者免疫损伤中的作用研究进展[J].新乡医学院学报,2022,39(4):392.[doi:10.7683/xxyxyxb.2022.04.019]
YANG Xin,YANG Daokun.Research progress on the role of toll like receptor in immunological injury of patients with chronic hepatitis B[J].Journal of Xinxiang Medical University,2022,39(04):392.[doi:10.7683/xxyxyxb.2022.04.019]